TD Asset Management Inc. Cuts Stock Holdings in Chemed Co. (NYSE:CHE)

TD Asset Management Inc. reduced its stake in Chemed Co. (NYSE:CHE) by 7.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 271,621 shares of the company’s stock after selling 21,039 shares during the quarter. TD Asset Management Inc. owned approximately 1.80% of Chemed worth $143,905,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in CHE. CIBC Asset Management Inc boosted its holdings in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company’s stock worth $242,000 after purchasing an additional 22 shares during the last quarter. CBIZ Investment Advisory Services LLC lifted its position in shares of Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after buying an additional 22 shares in the last quarter. EP Wealth Advisors LLC boosted its stake in shares of Chemed by 1.9% in the 3rd quarter. EP Wealth Advisors LLC now owns 1,354 shares of the company’s stock worth $814,000 after buying an additional 25 shares during the last quarter. Independent Advisor Alliance grew its holdings in shares of Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company’s stock valued at $1,207,000 after acquiring an additional 25 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Chemed by 7.1% during the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company’s stock valued at $264,000 after acquiring an additional 33 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Chemed Price Performance

Shares of CHE opened at $608.54 on Wednesday. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $646.71. The stock’s fifty day moving average price is $570.74 and its two-hundred day moving average price is $565.85. The firm has a market cap of $8.91 billion, a PE ratio of 30.75, a PEG ratio of 2.15 and a beta of 0.43.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed’s dividend payout ratio is currently 10.05%.

Insider Buying and Selling at Chemed

In other Chemed news, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average cost of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now owns 1,678 shares of the company’s stock, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. Insiders own 3.32% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Friday, March 7th. Royal Bank of Canada raised their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a report on Friday, March 14th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.